Drug profile · INN
tesamorelin
EGRIFTA
tesamorelin (EGRIFTA) is a growth hormone-releasing hormone receptor agonist.
EMA: application withdrawn NMPA: clinical trials
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — tesamorelin
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
tesamorelin (EGRIFTA) is a growth hormone-releasing hormone receptor agonist.
Key facts
INN tesamorelin
Brand EGRIFTA
Mechanism Growth hormone-releasing hormone receptor agonist
Mechanism of action
Growth hormone-releasing hormone receptor agonist
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | application withdrawn | — |
| NMPA | clinical trials | — |
Pipeline programs
Frequently asked questions
What is tesamorelin?
tesamorelin (EGRIFTA) is a growth hormone-releasing hormone receptor agonist.
What is the brand name for tesamorelin?
EGRIFTA is a marketed brand name for tesamorelin. Check FDA Drugs@FDA for the current US label holder and prescribing information.